{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Northborough",
      "state": "MA",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "78286",
      "recalling_firm": "Genzyme Corporation",
      "address_1": "11 Forbes Rd",
      "address_2": "N/A",
      "postal_code": "01532-2501",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0075-2018",
      "product_description": "Clolar (clofarabine) 20 mg/20 mL (1 mg/mL)  Injection, for intravenous use, Rx Only, Mfd. by: Teva Pharmachemie Swensweg 5   Haarlem, The Netherlands Mfd. for: Genzyme Corporation, Cambridge, MA 02142, NDC 0024-5860-01.",
      "product_quantity": "9,343 single dose vials",
      "reason_for_recall": "Labeling: Incorrect or Missing Package Insert.",
      "recall_initiation_date": "20171012",
      "center_classification_date": "20171110",
      "termination_date": "20200910",
      "report_date": "20171122",
      "code_info": "Lot #: K5006Y01; Exp. 08/31/18  Lot #: K5006Y03; Exp. 08/31/18    Lot #: K6001Y01; Exp. 03/31/19"
    }
  ]
}